Big Data Medicine Pharma Companies Production 
Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? Troy Groetken says that data has the ability to create personalised, predictive and preventative medicine tailored to individual patients and identified patient groups/populations.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 14, 2022
It has been quick to give reassurance that any analysis of patient data will comply with the EU’s data protection requirements. “Access to raw data can assist regulators in understanding the submitted evidence and therefore inform the regulatory decisions on the benefit-risk balance of the product,” it continues.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Drug Discovery World
FEBRUARY 6, 2024
Companies leading the way There are a number of companies leading the charge in applying innovative technologies, particularly artificial intelligence (AI) and machine learning (ML), to the search for new medicines. Universities are also using these digital technologies to advance their research.
Cloudbyz
SEPTEMBER 25, 2020
Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. With the advancement in digital technologies, data collection from end-users enables pharma companies to take notice of certain trends.
pharmaphorum
DECEMBER 22, 2021
For the past ten years we’ve seen a steady acceptance of the need for patient engagement practises to become routine and integrated into all systems of healthcare and the creation of new medicines and devices. Patients are beginning to expect the providers of their medicines to help them with their condition and the impact on their lives.
Expert insights. Personalized for you.
52 
Let's personalize your content